Bibliographic record
Abstract
Canada’s Drug Agency (CDA-AMC) recommends that Verzenio should be reimbursed by public drug plans for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer in patients who were postmenopausal in combination with nonsteroidal aromatase inhibitors (NSAIs) as an initial endocrine-based therapy, if certain conditions are met. Verzenio plus NSAI should be covered to treat adults with HR-positive, HER2-negative advanced or metastatic breast cancer, with a good performance status. Verzenio plus NSAI should not be covered in patients who have previously received cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors or received more than 1 line of chemotherapy for advanced or metastatic breast cancer. Verzenio plus NSAI should only be reimbursed if prescribed by clinicians with expertise in managing advanced or metastatic breast cancer and if the cost of Verzenio does not exceed the drug program cost of treatment with ribociclib plus NSAI, reimbursed for the indicated population.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".